ASA - American Society of Anesthesiologists

09/01/2026 | Press release | Distributed by Public on 09/01/2026 09:53

American Society of Anesthesiologists Announces 14-Year Collaboration with Masimo as a Corporate Supporter

CHICAGO - The American Society of Anesthesiologists (ASA) today announced the continuation of its longstanding collaboration with Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient-monitoring solutions , through ASA's Corporate Supporter Program. Now in its 14th year, the relationship supports education and initiatives designed to advance anesthesia care and help improve patient outcomes.

"As an anesthesiologist, I understand the critical role that education, innovation, and reliable technology play in delivering the highest-quality patient care," said ASA President Patrick Giam, M.D., FASA. "We welcome Masimo's continued collaboration and support through the ASA Corporate Supporter Program. Working together, we will advance the specialty, provide anesthesiologists with valuable resources, and ultimately improve outcomes for the patients we serve."

As a Corporate Supporter, Masimo continues to build on its longstanding relationship with the anesthesiology community, strengthen collaboration between anesthesiologists and industry, and add to the value the Society provides to members and their patients, while providing invaluable year-round support of ASA programs and priorities related to perioperative care.

Corporate Supporters have unique opportunities to inform strategic dialogue with leaders in anesthesiology from around the world and during major ASA events including the ANESTHESIOLOGY® annual meeting and ADVANCE: The Anesthesiology Business Event.

"Masimo has always believed that the best innovation starts with a deep understanding of clinicians and the patients they serve," said Tim Benner, president of Masimo. "For 14 years, our collaboration with ASA has given us an important opportunity to support the anesthesiology community through education, dialogue and shared learning. We're proud to continue that commitment as we work together to advance patient care and improve outcomes."

Established in 2010, ASA's Corporate Supporter Program is limited to 10 organizations. The program recognizes leading companies that demonstrate a sustained commitment to advancing the specialty of anesthesiology through support of education, innovation, and initiatives that benefit anesthesiologists and the Anesthesia Care Team.

ABOUT THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS
Founded in 1905, the American Society of Anesthesiologists (ASA) is an educational, research and scientific society with more than 60,000 members organized to advance the medical practice of anesthesiology and secure its future. ASA is committed to ensuring anesthesiologists evaluate and supervise the medical care of all patients before, during and after surgery. ASA members also lead the care of critically ill patients in intensive care units, as well as treat pain in both acute and chronic settings.

For more information on the field of anesthesiology, visit the American Society of Anesthesiologists online at asahq.org. To learn more about how anesthesiologists help ensure patient safety, visit asahq.org/madeforthismoment. Follow ASA on Facebook, X, Instagram, Bluesky, and LinkedIn.

ABOUT MASIMO
Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring solutions, develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. Our mission is for our innovations to empower clinicians to transform patient care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown to outperform other pulse oximetry technologies in over 100 independent and objective studies, which can be found at www.masimo.com/evidence/featured-studies/feature . Masimo SET® is estimated to be used on more than 200 million patients around the world each year and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2026 Newsweek World's Best Hospitals listing. Additional information about Masimo and its products may be found at www.masimo.com .

ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Through our connected ecosystem of industry-leading businesses, we work side by side with customers to solve their most complex scientific and clinical challenges - helping move innovations from discovery to delivery faster for patients who depend on them. Powered by the Danaher Business System, our advanced science and technology and proven ability to innovate help enable faster, more accurate diagnoses and reduce the time, cost, and risk required to discover, develop, and deliver life-changing therapies. Through continuous improvement and operational excellence, our approximately 60,000 associates worldwide are focused on delivering lasting impact and improving quality of life around the world, while building a healthier, more sustainable tomorrow. Explore more at www.danaher.com .

# # #

ASA - American Society of Anesthesiologists published this content on September 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 01, 2026 at 15:53 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]